Ajanta Pharma Faces Continued Decline Amid Broader Market Gains and Volatility

Ajanta Pharma has experienced a notable decline of 3.78% on May 2, 2025, underperforming the broader market, which saw the Sensex rise by 0.69%. The stock has been on a downward trend for the past three days, accumulating a total loss of 7.14% during this period. Today, Ajanta Pharma reached an intraday low of Rs 2558, reflecting a significant volatility of 31.39%.
In terms of moving averages, Ajanta Pharma is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend in the short to medium term. Over the past week, the stock has declined by 3.25%, while its performance over the last month shows a decrease of 0.94%.

Despite the recent downturn, Ajanta Pharma has shown resilience over the longer term, with a 1-year performance of 15.99% and a remarkable 210.06% increase over the past decade. However, year-to-date performance stands at a decline of 12.07%, contrasting sharply with the Sensex's gain of 3.40% in the same timeframe.